Tomas J. Heyman

Director at Exelixis · 5 reported transactions in 3 companies · latest report Sep 24, 2026

Their trades


Legend BiotechLEGN	Share award — · 20,986 shares	Sep 24, 2026
ExelixisEXEL	Share award — · 8,367 shares	May 27, 2026
Akero TherapeuticsAKRO	Returned to company — · 9,398 shares	Dec 9, 2025
Akero TherapeuticsAKRO	Share award — · 9,398 shares	Jun 3, 2025
ExelixisEXEL	Share award — · 9,812 shares	May 29, 2025

Share awardLegend Biotech

Sep 24, 2026 · LEGN

20,986

Share awardExelixis

May 27, 2026 · EXEL

8,367

Returned to companyAkero Therapeutics

Dec 9, 2025 · AKRO

9,398

Share awardAkero Therapeutics

Jun 3, 2025 · AKRO

9,398

Share awardExelixis

May 29, 2025 · EXEL

9,812

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.